ArticleRheumatology and therapy2026

Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study.

Laure Gossec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.